HIV viral load;HIV-Viruslast

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 42, 1996, Pages 1303-1308

  Muhlhofer A ^a   Bogner, J R ^a   Goebel, F D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; REVIEW; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; VIREMIA; VIROLOGY; VIRUS LOAD;

HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD; VIREMIA;

EID: 0030592365     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043144     Document Type: Review

References (32)

1. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), LB5 b.
2. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), S25.
3. Cao, Y., L. Qin, L. Zhang, J. Safrit, D. Ho: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. New Engl. J. Med. 332 (1995), 201-208.
4. Carpenter, C. J., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, P. A. Volberding: Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. J. Amer. med. Ass. 276 (1996), 146-154.
5. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A246.
6. Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevachari, R. T. Davey, J. A. Kovacs, N. P. Salzman, H. C. Lane, M. S. Ureda: Application of branched DNA signal amplification to monitor human deficiency virus type 1 burden in human plasma. J. infect. Dis. 170 (1994), 1172-1179.
7. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A260.
8. Eron, J. J., S. L. Beniot, R. D. MacArthur, J. Santana, J. B. Quinn, D. Kuritzkes, M. A. Fallon, M. Rubin: Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. New Engl. J. Med. 333 (1995), 1662-1669.
9. Gürtler, L. G.: Bestimmung der Virusmenge von HIV im Blut und ihrer Wertigkeit zur Messung der Effektivität von antiretroviraler Therapie. AIDS-Forsch. 10 (1995), 655-659.
10. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), S24.
11. Harrigan, R.: Measuring viral load in the clinical setting. J. acquir. Immune Defic. Syndr. 10, Suppl. 1 (1995), S34-S40.
12. Henrard, D., J. F. Phillips, L. R. Muenz, W. A. Blattner, D. Wiesner, M. E. Eyster, J. J. Goedert: Natural history of HIV-1 cell-free viraemia. J. Amer. med. Ass. 274 (1995), 554-558.
13. Ho, D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, M. Markowitz: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995), 123-126.
14. Hogervorst, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. van Gemen, R. Coutinho, F. Miedema, J. Goudsmit: Predictors for non- and slow progression in human deficiency virus (HIV) infection. Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. infect. Dis. 171 (1995), 811-821.
15. Kappes, J. C., M. S. Saag, G. M. Shaw, B. H. Hahn, P. Chopera, S. Chen, E. A. Emini, R. McFarland, L. Yang, M. Piatak: J. D. Lifson: Assessment of antiretroviral therapy by plasma viral load testing. Standards and ICD HIV-1 p24 antigen and viral RNA (QR-PCR) assays compared. J. acquir. Immune Defic. Syndr. 10 (1995), 139-149.
16. Kievits, T., P. Rothbart, W. Quint, H. Huisman, J. Goudsmit, P. Lens: NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. virol. Meth, 35 (1991), 272-286.
17. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A255.
18. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. Coombs, J. B. Jackson: Multicenter evaluation of quantification methods for human immunodeficiency virus type 1 RNA. J. infect. Dis. 170 (1994), 553-562.
19. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, J. A. Todd, B. S. Hoo, R. P. Kokka, P. Gupta: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. intern. Med. 122 (1995), 573-579.
20. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, L. A. Kingsley: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996), 1167-1170.
21. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A243.
22. rd Conference on Retroviruses and Opportunistic Infections (1996), A259.
23. Mulder, J., N. McKinney, C. Christopherson, J. Sinnsky, L. Greenfield, S. Kwok: Rapid and simple PCR assay for quantitation of human deficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32 (1995), 292-300.
24. O'Brien, W. A., P. Haartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, M. Simberkoff, J. D. Hamilton: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New Engl. J. Med. 334 (1996), 426-431.
25. rdConference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A247.
26. Reichelderfer, P. S., R. W. Coombs: Virological parameters as surrogate markers for clinical outcome in HIV-1 disease. Verification, variation and validation. J. acquir. Immune Defic. Syndr. 10. Suppl. 2 (1995), S19-S24.
27. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A256.
28. Schooley, R. T.: Correlation of viral load and clinical outcome. Fifth European Conference on Clinical Aspects of HIV infection. Falconer Scenen (1995), 32-33.
29. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), LB1.
30. rd Conference on Retroviruses and Opportunistic Infections, Washington, D. C. (1996), A249.
31. Todd, J., C. Pachl, R. White, T. Yeghiazarian, P. Johnson, B. Taylor, M. Holodniy, D. Kern, S. Hamren, D. Chernoff, M. Urdea: Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. acquir. Immune Deficiency Syndr. 10, Suppl. 2 (1995), S35-S44.
32. Zhang, Y., K. Nakata, M. Weiden, W. N. Rom: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J. clin. Invest. 95 (1995), 2324-2331.